We confirmed that MB-PDT decreases the proliferation of NSCLC cell lines, inhibiting the expression of anti-apoptotic Bcl2 protein and activating caspase 3/7, a marker of apoptosis. The gene discussed is CASP3; the disease is non-small cell lung carcinoma.